Exopolysaccharide Produced by Plant-Derived Lactobacillus plantarum SN35N Exhibits Antiviral Activity.
Animals
Anti-Inflammatory Agents
/ pharmacology
Antiviral Agents
/ isolation & purification
Calicivirus, Feline
/ drug effects
Cats
Dogs
Hyaluronoglucosaminidase
Lactobacillales
Lactobacillus plantarum
/ classification
Madin Darby Canine Kidney Cells
Norovirus
/ drug effects
Orthomyxoviridae
/ drug effects
Polysaccharides, Bacterial
/ isolation & purification
Pyrus
/ microbiology
Species Specificity
Lactobacillus plantarum
antivirus
exopolysaccharide
lactic acid bacteria
Journal
Biological & pharmaceutical bulletin
ISSN: 1347-5215
Titre abrégé: Biol Pharm Bull
Pays: Japan
ID NLM: 9311984
Informations de publication
Date de publication:
2021
2021
Historique:
entrez:
2
12
2021
pubmed:
3
12
2021
medline:
1
2
2022
Statut:
ppublish
Résumé
A lactic acid bacterial strain, Lactobacillus plantarum SN35N, which has been isolated from the pear, secretes negatively charged acidic exopolysaccharide (EPS) to outside cells. We have previously found that the SN35N-derived acidic EPS inhibits the catalytic activity of hyaluronidase (EC 3.2.1.35) promoting inflammation. The aim of this study is to find other health benefits of EPS. EPS has been found to exhibit an inhibitory effect against the influenza virus (Alphainfluenzavirus Influenza A virus) and feline calicivirus (Vesivirus Feline calicivirus), which is recognized as a model of norovirus. Although more studies on the structure-function relationship of EPSs are needed, SN35N-derived EPS is a promising lead for developing not only anti-inflammatory agents, but also antiviral substances.
Identifiants
pubmed: 34853272
doi: 10.1248/bpb.b21-00517
doi:
Substances chimiques
Anti-Inflammatory Agents
0
Antiviral Agents
0
Polysaccharides, Bacterial
0
Hyaluronoglucosaminidase
EC 3.2.1.35
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM